Tag archive for ‘AndexXa approval on May 4’
Portola: Why I Think that AndexXa is Likely to be Approved (PTLA, Buy, $36.44)
Key Observations and Conclusions I believe there is a very strong possibility that AndexXa will be approved on its PDUFA date of May 4, 2018 even though the phase 3 trial that is the basis of the BLA leaves much to be desired. It is based on a single AndexXa arm which at this point […]